Cue Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cue Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.17 | $-0.19 | 10.5 % |
Jun 2024 | 2024-08-14 | $-0.20 | $-0.29 | 31.0 % |
Mar 2024 | 2024-05-09 | $-0.25 | $-0.28 | 10.7 % |
Mar 2024 | 2024-04-08 | $-0.28 | $-0.28 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $3.34M | $1.52M | 119.5 % |
Jun 2024 | 2024-08-14 | $2.66M | $1.29M | 106.0 % |
Mar 2024 | 2024-05-09 | $1.72M | $1.21M | 41.9 % |
Mar 2024 | 2024-04-08 | $1.82M | $1.71M | 6.49 % |
Cue Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Cue Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.17, which beat the estimate of $-0.19.
Cue Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.